Repligen Company (RGEN) 2026 KeyBanc Capital Markets Healthcare Digital Discussion board March 18, 2026 2:15 PM EDT
Firm Individuals
Olivier Loeillot – President, CEO & Director
Jason Garland – CFO & Chief Compliance Officer
Convention Name Individuals
Paul Knight – KeyBanc Capital Markets Inc., Analysis Division
Anna Snopkowski – KeyBanc Capital Markets Inc., Analysis Division
Presentation
Paul Knight
KeyBanc Capital Markets Inc., Analysis Division
That is Paul Knight, life science analyst at Repligen. And with us, we now have Jacob Johnson, Head of Investor Relations; Jason, Chief Monetary Officer; Olivier, CEO. All of us very acquainted with Repligen administration. In reality, once I first met them at $3 a share, it was within the constructing I am sitting in proper now at 1301 Sixth Avenue.
Query-and-Reply Session
Paul Knight
KeyBanc Capital Markets Inc., Analysis Division
So that they’ve come a great distance. And Olivier, you’ve got been there — you’ve got not been there eternally. What are your impressions now because the CEO a little bit of how Repligen is positioned and the way this market feels to you?
Olivier Loeillot
President, CEO & Director
Sure. No, that is an ideal query, Paul. I imply I have been right here for about 2.5 years now, CEO of the corporate for 1.5 years. I imply, I am clearly extra excited than ever. I imply we now have a really distinctive and really broad providing on the similar time. And with our very intense industrial technique, I imply, we have been very profitable during the last couple of years to actually get increasingly more nearer to these huge firms and getting them understanding we now have a really broad portfolio of merchandise.
You already know very properly, like innovation has at all times been actually on the core of our DNA, and we’re nonetheless doubling down on innovation as properly as a result of we actually wish to make sure that we’re serving to our clients to